BDX
BECTON DICKINSON & CO
Surgical & Medical Instruments & Apparatus- 売上
- $21.8bn
- 時価総額
- $47.8bn
株価 $165.45 · 100株 2万円
| 期 | 23/09 | 24/09 | 25/09 |
|---|---|---|---|
| 売上 | $19.4bn | $20.2bn | $21.8bn |
| 成長率 | — | 4.2% | 8.2% |
| 総利益 | $7.6bn | $7.6bn | $7.6bn |
| 総利益率 | 39.1% | 37.6% | 34.7% |
| 販管費 | $4.7bn | $4.9bn | $5.3bn |
| 販管費率 | 24.4% | 24.1% | 24.2% |
| 営利 | $2.1bn | $2.4bn | $2.6bn |
| 営利率 | 10.9% | 11.9% | 11.8% |
| 純利益 | $1.5bn | $1.7bn | $1.7bn |
| PBR | 1.9 | 1.8 | 1.9 |
| PSR | 2.5 | 2.4 | 2.2 |
| PGPR | 6.3 | 6.3 | 6.3 |
| PER | 32 | 28 | 29 |
| ﾈｯﾄｷｬｯｼｭ | ▲$14.5bn | ▲$18.4bn | ▲$18.5bn |
| EV/EBITDA | 14.2 | 14.1 | 13.2 |
| Rule of 40 | — | 16% | 20% |
| セールス効率 | — | 0% | 0% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）